WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02269 WUXI BIO

Trading 06-29 14:22:31

35.340

+2.300

+6.96%

High35.660	Low33.140	Vol33.72M
Open33.800	D1 Closing33.040	Amplitude7.63%
Mkt Cap146.41B	Tradable Cap146.41B	Total Shares4.14B
T/O1.17B	T/O Rate0.81%	Tradable Shares4.14B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02269","market":"HK","secType":"STK","nameCN":"WUXI BIO","latestPrice":35.34,"timestamp":1782714148299,"preClose":33.04,"halted":0,"volume":33720163,"delay":0,"changeRate":0.0696125907990316,"floatShares":4143000000,"shares":4143000000,"eps":1.3389540716375303,"marketStatus":"Trading","change":2.3,"latestTime":"06-29 14:22:31","open":33.8,"high":35.66,"low":33.14,"amount":1174412753,"amplitude":0.076271,"askPrice":35.34,"askSize":19500,"bidPrice":35.32,"bidSize":6000,"shortable":3,"etf":0,"ttmEps":1.3389540716375303,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1782720600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1497283200000,"exchange":"SEHK","adjPreClose":33.04,"openAndCloseTimeList":[[1782696600000,1782705600000],[1782709200000,1782720000000]],"volumeRatio":1.487493,"optionData":{"bulkOrders":[{"symbol":"WXB.HK","call":true,"expireDate":1782662400000,"strike":"35.00","timestamp":1782698272507,"price":0.2,"volume":300,"amount":30000,"type":"*"},{"symbol":"WXB.HK","call":false,"expireDate":1790611200000,"strike":"22.00","timestamp":1782698877580,"price":0.22,"volume":270,"amount":29700,"type":"*"}]},"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"WXB.HK","impliedVol":0.5859,"impliedVolPercentile":0.902},"requestUrl":"/m/hq/s/02269","defaultTab":"news","newsList":[{"id":"1109217352","title":"Movement Alert｜WuXi Biologics Rises 3.39% in Regular Trading, Sustained Buybacks and CXO Sector Resonance Drive Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=1109217352","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109217352?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:58","pubTimestamp":1782698292,"startTime":"0","endTime":"0","summary":"On June 29, WuXi Biologics rose 3.39% in regular trading, reaching HK$34.4 per share, with turnover of HK$254 million.On the news front, the company has maintained a high-frequency buyback pace,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646354524","title":"TOT Biopharm Shareholders Approve All AGM Resolutions by Poll","url":"https://stock-news.laohu8.com/highlight/detail?id=2646354524","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646354524?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:32","pubTimestamp":1782473521,"startTime":"0","endTime":"0","summary":"TOT Biopharm shareholders approve all AGM resolutions by pollTOT BIOPHARM International held its annual general meeting on June 26, 2026.Shareholders received and adopted the audited consolidated fina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL93J4Nm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0039217434.USD","LU2039709279.SGD","BK1610","LU3063872942.SGD","LU0417516902.SGD","LU0140636845.USD","LU0819121731.USD","LU0326950275.SGD","LU1242518931.SGD","LU0052750758.USD","BK1589","LU0456827905.SGD","LU1794554557.SGD","LU0708995583.HKD","01875","LU0516423174.USD","LU1688375341.USD","LU0456846285.SGD","LU0823426480.USD","LU0823426308.USD","LU0043850808.USD","IE00B0JY6N72.USD","LU0516422952.EUR","LU0516422366.SGD","LU0516422440.USD","BK1161","LU0051755006.USD","LU0348735423.USD","BK1141","BK1574","LU0327786744.USD","LU0307460666.USD","BK1521","SG9999002463.SGD","LU0417516738.SGD","BK1576","LU0181495838.USD","LU0359201612.USD","LU0359202008.SGD","SG9999002562.SGD","LU0320764599.SGD","LU0348825331.USD","LU0516423091.SGD","LU1880383366.USD","LU0856984785.SGD","LU0979878070.USD","02269","LU0588546209.SGD","LU0572944931.SGD","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646356696","title":"Wuxi Biologics Says Sbti Validates New Emissions Target Matrix, Reaffirms 2050 Net-zero Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2646356696","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646356696?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:10","pubTimestamp":1782468655,"startTime":"0","endTime":"0","summary":"WuXi Biologics says SBTi validates new emissions target matrix, reaffirms 2050 net-zero goalWuXi Biologics highlighted its Green CRDMO strategy at the 2026 Summer Davos, positioning sustainability as ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDLJLVgX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU0359202008.SGD","LU0456846285.SGD","SG9999002562.SGD","BK1576","02269","LU0052750758.USD","LU0516422366.SGD","LU0823426480.USD","LU1794554557.SGD","LU0708995583.HKD","LU2039709279.SGD","LU0359201612.USD","LU0516423091.SGD","LU0856984785.SGD","LU0572944931.SGD","LU0326950275.SGD","SG9999002463.SGD","LU0819121731.USD","LU0417516738.SGD","LU0516422952.EUR","BK1521","LU0181495838.USD","LU0417516902.SGD","LU0588546209.SGD","LU0456827905.SGD","LU0979878070.USD","LU0516423174.USD","LU0307460666.USD","IE00B0JY6N72.USD","LU1242518857.USD","LU1242518931.SGD","LU1688375341.USD","LU0516422440.USD","LU0320764599.SGD","LU0051755006.USD","LU0140636845.USD","LU0348735423.USD","LU1720050803.USD","LU0327786744.USD","LU0039217434.USD","BK1589","LU0823426308.USD","LU0043850808.USD","LU3063872942.SGD","LU0348825331.USD","BK1610","LU1880383366.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646135392","title":"Wuxi XDC Cayman Held Annual General Meeting, Shareholders Passed All Resolutions by Poll","url":"https://stock-news.laohu8.com/highlight/detail?id=2646135392","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646135392?lang=en_us&edition=fundamental","pubTime":"2026-06-26 17:28","pubTimestamp":1782466124,"startTime":"0","endTime":"0","summary":"WuXi XDC Cayman held annual general meeting, shareholders passed all resolutions by pollShareholders of Wuxi XDC Cayman met on June 26, 2026, passing all resolutions put to the annual general meeting.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL29VXbJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359202008.SGD","LU2488822045.USD","LU0516423174.USD","02268","LU0456827905.SGD","SG9999002463.SGD","LU1794554557.SGD","LU0516422366.SGD","LU1880383366.USD","LU0572944931.SGD","LU0043850808.USD","LU0181495838.USD","LU0348825331.USD","LU0417516902.SGD","LU0140636845.USD","BK1576","LU0516422952.EUR","LU0051755006.USD","LU0348735423.USD","LU0327786744.USD","LU0516423091.SGD","LU0856984785.SGD","LU1720050803.USD","LU1688375341.USD","LU0359201612.USD","LU0320764599.SGD","LU0708995583.HKD","BK1521","LU0819121731.USD","LU0823426480.USD","IE00B0JY6N72.USD","LU3063872942.SGD","LU0588546209.SGD","LU1242518931.SGD","LU0979878070.USD","BK1610","02269","LU0039217434.USD","LU2039709279.SGD","LU0823426308.USD","LU0326950275.SGD","LU0456846285.SGD","SG9999002562.SGD","BK1141","LU0052750758.USD","LU1242518857.USD","SG9999014674.SGD","LU0307460666.USD","BK1589","LU0516422440.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646035396","title":"Wuxi XDC Appoints Yuan Fang Joint Company Secretary, Authorized Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=2646035396","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646035396?lang=en_us&edition=fundamental","pubTime":"2026-06-26 17:26","pubTimestamp":1782466014,"startTime":"0","endTime":"0","summary":"WuXi XDC appoints Yuan Fang joint company secretary, authorized representativeWuXi XDC named Yuan Fang joint company secretary, effective June 26, 2026; she also becomes an authorized representative.F","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL6Y0xcy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0348735423.USD","02137","LU1720050803.USD","SG9999002463.SGD","LU0181495838.USD","LU0327786744.USD","02268","LU0823426480.USD","LU2488822045.USD","LU1242518857.USD","LU3063872942.SGD","LU0819121731.USD","LU1688375341.USD","LU0456846285.SGD","BK1141","BK1589","LU0588546209.SGD","LU0043850808.USD","LU0051755006.USD","LU0307460666.USD","LU0979878070.USD","LU0516422440.USD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0516422366.SGD","BK4139","LU0516422952.EUR","LU0039217434.USD","LU2039709279.SGD","LU0320764599.SGD","LU0348825331.USD","LU0516423091.SGD","BK1587","BK1521","LU0516423174.USD","NBP","LU1880383366.USD","LU0417516902.SGD","BK1610","LU1242518931.SGD","LU0456827905.SGD","LU0140636845.USD","LU0359202008.SGD","LU0417516738.SGD","LU1794554557.SGD","LU0052750758.USD","LU0572944931.SGD","02269","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646873387","title":"Wuxi Biologics (cayman) Stock Climbs 2.0% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2646873387","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646873387?lang=en_us&edition=fundamental","pubTime":"2026-06-25 16:32","pubTimestamp":1782376320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. advanced 2.0% to 33.10 Hong Kong dollars on what proved to be an all-around dismal trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.4% to 23076.91.This was the stock's third consecutive day of gains.Wuxi Biologics  Inc. closed 25% short of its 52-week high of HK$44.00, which the company reached Feb. 12.Trading volume totaled 33.2 million shares, compared to the 50-day average of 27.9 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 25, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","LU0327786744.USD","LU0572944931.SGD","BK1521","LU1242518931.SGD","LU0856984785.SGD","BK1141","LU0348735423.USD","LU0516423091.SGD","LU0348825331.USD","LU0307460666.USD","LU0516423174.USD","BK1576","LU1794554557.SGD","LU0417516902.SGD","LU0823426308.USD","LU0456846285.SGD","LU0516422366.SGD","LU0051755006.USD","LU0320764599.SGD","LU0417516738.SGD","LU0588546209.SGD","LU0516422440.USD","LU0708995583.HKD","LU0819121731.USD","LU3063872942.SGD","LU2039709279.SGD","LU0326950275.SGD","LU0979878070.USD","LU0043850808.USD","SG9999002562.SGD","LU1688375341.USD","LU0516422952.EUR","LU0052750758.USD","LU0140636845.USD","SG9999002463.SGD","LU1880383366.USD","02269","IE00B0JY6N72.USD","LU1720050803.USD","LU0823426480.USD","BK1589","LU0039217434.USD","LU0359201612.USD","LU0359202008.SGD","LU0181495838.USD","BK1610","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113758888","title":"Movement Alert｜WuXi Biologics Rises 3.27% in Regular Trading, Sustained Buybacks and CXO Sector Momentum Drive Stock Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1113758888","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113758888?lang=en_us&edition=fundamental","pubTime":"2026-06-25 11:09","pubTimestamp":1782356985,"startTime":"0","endTime":"0","summary":"On June 25, WuXi Biologics rose 3.27% in regular trading, trading at HKD 33.34/share, with turnover of HKD 325 million.On the news front, the company has conducted consecutive buybacks over recent...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645992018","title":"Wuxi Apptec Shares Rally Amid Sectorwide Gains After Tech Selloff, China Policy Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2645992018","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645992018?lang=en_us&edition=fundamental","pubTime":"2026-06-24 17:49","pubTimestamp":1782294540,"startTime":"0","endTime":"0","summary":"Shares of Chinese biopharmaceutical company WuXi AppTec surged Wednesday as investors turned to healthcare stocks amid a global tech selloff and were encouraged by fresh policy support from Beijing.Wu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0516422952.EUR","SG9999014674.SGD","LU0039217434.USD","02269","LU0140636845.USD","LU3063872942.SGD","LU0819121731.USD","LU1242518857.USD","LU1720050803.USD","LU0320764599.SGD","LU0417516738.SGD","LU1719994722.HKD","LU0516422366.SGD","LU0348825331.USD","LU0979878070.USD","BK1589","SG9999002463.SGD","LU1979443071.USD","LU0708995583.HKD","LU1969619763.USD","LU0307460666.USD","LU0456846285.SGD","LU1303224171.USD","603259","LU0823426308.USD","LU2488822045.USD","BK0216","LU0043850808.USD","BK1576","02268","LU0359202008.SGD","LU0417516902.SGD","LU0516422440.USD","LU0516423091.SGD","LU1997244956.HKD","LU0051755006.USD","LU2039709279.SGD","LU0516423174.USD","LU2328871848.SGD","LU0348735423.USD","IE00BPRC5H50.USD","LU0456827905.SGD","LU0327786744.USD","LU0588546209.SGD","LU1808992512.USD","LU0572944931.SGD","BK1141","SG9999002562.SGD","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645893576","title":"WuXi Biologics completes first GMP production at new Shanghai MFG17 drug substance plant","url":"https://stock-news.laohu8.com/highlight/detail?id=2645893576","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645893576?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:13","pubTimestamp":1782288790,"startTime":"0","endTime":"0","summary":"WuXi Biologics completed first GMP production at its MFG17 drug substance facility in Shanghai, marking its 25th drug substance plant.Execution recorded zero deviations, with stable critical parameters and yields meeting expectations.MFG17 adds 9,000 liters of single-use bioreactor capacity, targeting 80-100 batches a year for clinical to commercial supply.Site is positioned to support scale-up, technology transfer, multi-regional registrations, and dual-sourcing across the company’s global network.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics  Inc. published the original content used to generate this news brief on June 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL9bfqzs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518931.SGD","LU0181495838.USD","SG9999002463.SGD","LU0052750758.USD","LU1242518857.USD","LU2039709279.SGD","BK1610","LU0140636845.USD","LU1794554557.SGD","LU1880383366.USD","LU0417516738.SGD","LU0327786744.USD","LU0819121731.USD","LU0516422952.EUR","LU0856984785.SGD","IE00B0JY6N72.USD","LU0456846285.SGD","LU0320764599.SGD","LU0516423174.USD","LU0456827905.SGD","BK1521","LU0043850808.USD","LU0417516902.SGD","LU0823426480.USD","SG9999002562.SGD","LU0572944931.SGD","LU0051755006.USD","LU0359201612.USD","LU0039217434.USD","LU0348735423.USD","LU0823426308.USD","LU0359202008.SGD","LU0516423091.SGD","LU1688375341.USD","LU1720050803.USD","LU0516422440.USD","BK1576","LU0307460666.USD","LU3063872942.SGD","BK1141","LU0348825331.USD","LU0979878070.USD","BK1589","LU0588546209.SGD","LU0708995583.HKD","LU0326950275.SGD","02269","LU0516422366.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183673571","title":"Movement Alert｜WuXi Biologics Rises 4.24% in Regular Trading, Consecutive Buybacks and Sector Momentum Lift Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1183673571","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183673571?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:45","pubTimestamp":1782265520,"startTime":"0","endTime":"0","summary":"On June 24, WuXi Biologics rose 4.24% in regular trading, trading at HKD 32.18/share, with turnover of HKD 128 million.On the news front, the company has conducted buybacks for three consecutive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645839785","title":"WuXi Biologics files HKEX next-day disclosure return, issues 15,000 new shares via option exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=2645839785","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645839785?lang=en_us&edition=fundamental","pubTime":"2026-06-23 21:02","pubTimestamp":1782219737,"startTime":"0","endTime":"0","summary":"WuXi Biologics filed a next-day disclosure return dated June 23, 2026 covering share issuance from option exercises.Issued 15,000 new ordinary shares at HKD 1.71 per share under its Pre-IPO Share Option Scheme.Repurchased 1,605,000 ordinary shares on-market on June 23 for HKD 49.84 million, at HKD 30.62–31.34 per share.Issued share count rose to 4,142,714,417 as of June 23; treasury shares remained at zero.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL9J9HBf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0856984785.SGD","LU0327786744.USD","LU0708995583.HKD","LU1688375341.USD","LU0516422952.EUR","LU0823426308.USD","LU0456827905.SGD","LU0516422366.SGD","LU0359202008.SGD","LU0516422440.USD","LU0039217434.USD","BK1589","LU0348825331.USD","LU2039709279.SGD","LU0307460666.USD","BK1576","LU0052750758.USD","LU1242518931.SGD","LU1880383366.USD","IE00B0JY6N72.USD","SG9999002562.SGD","LU0140636845.USD","LU0348735423.USD","LU0588546209.SGD","LU1794554557.SGD","LU0043850808.USD","BK1610","LU0417516902.SGD","LU0979878070.USD","LU0456846285.SGD","LU0181495838.USD","LU0516423174.USD","LU0417516738.SGD","LU0572944931.SGD","LU0326950275.SGD","LU3063872942.SGD","BK1141","BK1521","LU0359201612.USD","LU0819121731.USD","SG9999002463.SGD","LU0823426480.USD","LU1720050803.USD","LU1242518857.USD","LU0051755006.USD","02269","LU0320764599.SGD","LU0516423091.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645288187","title":"Wuxi Biologics (Cayman) Stock Climbs 1.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2645288187","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645288187?lang=en_us&edition=fundamental","pubTime":"2026-06-23 16:33","pubTimestamp":1782203580,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 1.3% to 31.14 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.8% to 23336.28.Wuxi Biologics  Inc. closed 29% below its 52-week high of HK$44.00, which the company achieved Feb. 12.Trading volume totaled 26.9 million shares, compared to the 50-day average of 27.5 million shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1794554557.SGD","LU1688375341.USD","SG9999002562.SGD","LU0516423091.SGD","LU0348735423.USD","LU0051755006.USD","LU0181495838.USD","LU0708995583.HKD","LU0856984785.SGD","LU0052750758.USD","LU0516422952.EUR","BK1589","IE00B0JY6N72.USD","LU0348825331.USD","LU0417516902.SGD","BK1141","LU1242518857.USD","LU0417516738.SGD","LU0516423174.USD","LU0819121731.USD","LU0516422366.SGD","LU1880383366.USD","SG9999002463.SGD","LU0823426480.USD","BK1610","LU0359201612.USD","LU2039709279.SGD","LU0588546209.SGD","LU0359202008.SGD","LU1242518931.SGD","LU0516422440.USD","02269","LU0456827905.SGD","LU3063872942.SGD","LU0572944931.SGD","LU0307460666.USD","LU0140636845.USD","LU0823426308.USD","LU0456846285.SGD","LU0979878070.USD","LU0327786744.USD","LU1720050803.USD","BK1576","LU0043850808.USD","BK1521","LU0320764599.SGD","LU0039217434.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145139736","title":"Movement Alert｜WuXi Biologics Rises 3.06% in Regular Trading, Sustained Buybacks and Sector Recovery Boost Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1145139736","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145139736?lang=en_us&edition=fundamental","pubTime":"2026-06-23 10:02","pubTimestamp":1782180140,"startTime":"0","endTime":"0","summary":"On June 23, WuXi Biologics rose 3.06% in regular trading, trading at HK$31.66/share, with turnover of HK$121 million.On the news front, the company has been intensifying its share repurchase program....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178222691","title":"HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178222691","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178222691?lang=en_us&edition=fundamental","pubTime":"2026-06-23 09:56","pubTimestamp":1782179815,"startTime":"0","endTime":"0","summary":"Hong Kong-listed biotech stocks jumped on Tuesday. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up around 5%; Joinn, Remegen up about 4%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09995","03347","06606","09688","02359","02137","03759","09966","09606","06978","02268","02269","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104887570","title":"WUXI BIO Executes Share Buyback, Spending HK$49.24 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1104887570","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104887570?lang=en_us&edition=fundamental","pubTime":"2026-06-22 22:14","pubTimestamp":1782137654,"startTime":"0","endTime":"0","summary":"WUXI BIO (HKEX: 02269) has announced a significant share repurchase transaction.The company disclosed that on June 22, 2026, it allocated HK$49.24 million to buy back 1.6 million of its own shares.The repurchase price for the shares ranged between HK$30.66 and HK$31.14 per share.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","LU0823426308.USD","LU0043850808.USD","BK1141","LU0516422440.USD","SG9999002562.SGD","LU0348735423.USD","LU0456827905.SGD","BK1589","LU0326950275.SGD","LU0039217434.USD","LU0979878070.USD","LU0819121731.USD","02269","LU0516422366.SGD","LU0516423174.USD","LU1794554557.SGD","LU1242518857.USD","LU0051755006.USD","LU3063872942.SGD","LU0708995583.HKD","LU0140636845.USD","LU0588546209.SGD","LU0856984785.SGD","LU0516423091.SGD","LU1688375341.USD","LU0359202008.SGD","LU1242518931.SGD","LU2039709279.SGD","LU0052750758.USD","LU0417516902.SGD","LU0348825331.USD","LU0327786744.USD","IE00B0JY6N72.USD","LU0320764599.SGD","BK1610","LU0516422952.EUR","BK1521","LU0456846285.SGD","LU1720050803.USD","LU0359201612.USD","LU0181495838.USD","SG9999002463.SGD","BK1576","LU1880383366.USD","LU0823426480.USD","LU0307460666.USD","LU0572944931.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156186257","title":"Movement Alert｜WuXi Biologics Falls 3.24% in Regular Trading, Trading at 29.76 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1156186257","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156186257?lang=en_us&edition=fundamental","pubTime":"2026-06-22 10:06","pubTimestamp":1782093992,"startTime":"0","endTime":"0","summary":"On June 22, WuXi Biologics fell 3.24% in regular trading, trading at 29.76 HKD/share, with turnover of 222 million HKD.Within the Life Sciences Tools & Services sector where WuXi Biologics belongs,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644985740","title":"WuXi Biologics (Cayman) (SEHK:2269) Stock Could Be 34.3% Undervalued After Clean EMA Inspection","url":"https://stock-news.laohu8.com/highlight/detail?id=2644985740","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644985740?lang=en_us&edition=fundamental","pubTime":"2026-06-20 19:31","pubTimestamp":1781955097,"startTime":"0","endTime":"0","summary":"Why the EMA inspection matters for WuXi Biologics (Cayman)\nThe latest move in WuXi Biologics (Cayman) (SEHK:2269) stock comes after its Suzhou Biosafety Testing Center passed a four day European Medicines Agency GMP inspection with zero critical findings, backing 19 EU biologics applications.\nFor investors, this clean outcome highlights that a key part of WuXi Biologics (Cayman)'s testing and quality control operations aligns with European regulatory expectations, which can be important when...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-stock-could-be-343-undervalue","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2269/wuxi-biologics-cayman-shares/news/wuxi-biologics-cayman-sehk2269-stock-could-be-343-undervalue","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0326950275.SGD","LU0039217434.USD","BK1521","LU1242518857.USD","LU0588546209.SGD","02269","SG9999002463.SGD","LU0516422440.USD","LU0819121731.USD","LU1720050803.USD","LU0348735423.USD","LU1242518931.SGD","LU0516422952.EUR","LU0052750758.USD","LU0051755006.USD","BK1141","LU0708995583.HKD","LU0516422366.SGD","LU0823426480.USD","LU2039709279.SGD","LU0516423174.USD","LU0140636845.USD","LU0516423091.SGD","BK1610","LU0181495838.USD","LU0417516902.SGD","SG9999002562.SGD","LU0417516738.SGD","LU0348825331.USD","BK1589","LU1688375341.USD","IE00B0JY6N72.USD","LU1880383366.USD","EMA","LU0856984785.SGD","LU0359201612.USD","BK1576","LU0307460666.USD","LU0572944931.SGD","LU0359202008.SGD","LU0456846285.SGD","LU0320764599.SGD","BK4081","LU0327786744.USD","LU3063872942.SGD","LU0979878070.USD","LU1794554557.SGD","LU0043850808.USD","LU0823426308.USD","LU0456827905.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141625918","title":"WUXI BIO Executes Major Share Buyback, Spending Nearly HK$100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1141625918","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141625918?lang=en_us&edition=fundamental","pubTime":"2026-06-18 22:10","pubTimestamp":1781791818,"startTime":"0","endTime":"0","summary":"WUXI BIO (02269) has announced a significant share repurchase operation conducted on June 18, 2026.The company allocated a substantial HK$99.735 million to buy back 3.26 million of its own shares on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","LU0348735423.USD","LU0823426480.USD","02269","BK1141","LU0856984785.SGD","LU0417516738.SGD","BK1610","LU0588546209.SGD","LU0823426308.USD","BK1576","LU0979878070.USD","LU3063872942.SGD","LU0516423091.SGD","LU0043850808.USD","LU0708995583.HKD","LU0819121731.USD","LU1794554557.SGD","LU0516423174.USD","LU0359202008.SGD","LU0359201612.USD","LU0140636845.USD","LU0572944931.SGD","LU0327786744.USD","LU1880383366.USD","LU1242518857.USD","LU1242518931.SGD","SG9999002562.SGD","LU0181495838.USD","LU0052750758.USD","LU0456846285.SGD","IE00B0JY6N72.USD","LU0516422366.SGD","BK1589","LU0456827905.SGD","LU2039709279.SGD","LU0516422440.USD","LU1720050803.USD","LU0051755006.USD","SG9999002463.SGD","LU0320764599.SGD","LU0417516902.SGD","LU1688375341.USD","BK1521","LU0039217434.USD","LU0348825331.USD","LU0516422952.EUR","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177764641","title":"WuXi Biologics Adds 0.16 Million New Shares from Option Exercises, While Repurchasing 3.26 Million Shares for HKD 99.74 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1177764641","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177764641?lang=en_us&edition=fundamental","pubTime":"2026-06-18 22:04","pubTimestamp":1781791476,"startTime":"0","endTime":"0","summary":"WuXi Biologics (Cayman) Inc. disclosed on 18 June 2026 that it has made marginal additions to, and substantial repurchases of, its share capital over the past week, according to its latest Next Day...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644081342","title":"WuXi Biologics files HKEX next-day disclosure return, issues 155,000 new shares via option exercises","url":"https://stock-news.laohu8.com/highlight/detail?id=2644081342","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644081342?lang=en_us&edition=fundamental","pubTime":"2026-06-18 22:03","pubTimestamp":1781791381,"startTime":"0","endTime":"0","summary":"WuXi Biologics filed a next-day disclosure return on June 18, 2026, reporting 155,000 new ordinary shares issued from share option exercises.Issued share count rose to 4,142,673,417 as of June 18.It also repurchased 3,260,000 shares on June 18 for cancellation, paying HKD 99.74 million at HKD 29.24 to HKD 31.24 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wuxi Biologics  Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL99K40T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","LU0516423174.USD","LU1242518931.SGD","LU0348825331.USD","LU0181495838.USD","BK1576","LU0823426308.USD","LU0052750758.USD","LU0417516902.SGD","LU0516422952.EUR","LU0417516738.SGD","LU1720050803.USD","LU0516423091.SGD","LU0039217434.USD","LU0456827905.SGD","LU0516422366.SGD","BK1521","LU0588546209.SGD","LU0708995583.HKD","LU0326950275.SGD","LU0572944931.SGD","BK1141","SG9999002463.SGD","LU0359202008.SGD","LU1242518857.USD","LU0051755006.USD","LU1880383366.USD","LU0140636845.USD","BK1589","LU0359201612.USD","LU0456846285.SGD","LU0043850808.USD","LU3063872942.SGD","LU0307460666.USD","LU0320764599.SGD","LU0327786744.USD","LU0823426480.USD","LU1794554557.SGD","SG9999002562.SGD","LU1688375341.USD","LU0348735423.USD","LU0856984785.SGD","LU2039709279.SGD","BK1610","02269","LU0819121731.USD","IE00B0JY6N72.USD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.072},{"period":"1month","weight":-0.019},{"period":"3month","weight":0.021},{"period":"6month","weight":0.0135},{"period":"1year","weight":0.3216},{"period":"ytd","weight":0.0509}],"compareEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.1049},{"period":"3month","weight":-0.0914},{"period":"6month","weight":-0.1219},{"period":"1year","weight":-0.068},{"period":"ytd","weight":-0.1154}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"WuXi Biologics (Cayman) Inc is an investment holding company principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. The Company mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The Company mainly conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.052868},{"month":2,"riseRate":0.555556,"avgChangeRate":0.006907},{"month":3,"riseRate":0.555556,"avgChangeRate":-0.001977},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.000488},{"month":5,"riseRate":0.555556,"avgChangeRate":0.002485},{"month":6,"riseRate":0.555556,"avgChangeRate":0.056408},{"month":7,"riseRate":0.666667,"avgChangeRate":0.081469},{"month":8,"riseRate":0.555556,"avgChangeRate":0.030253},{"month":9,"riseRate":0.666667,"avgChangeRate":0.056337},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.033632},{"month":11,"riseRate":0.444444,"avgChangeRate":0.025584},{"month":12,"riseRate":0.555556,"avgChangeRate":0.009161}],"exchange":"SEHK","name":"WUXI BIO","nameEN":"WUXI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"WUXI BIO,02269,WUXI BIO股票,WUXI BIO股票老虎,WUXI BIO股票老虎国际,WUXI BIO行情,WUXI BIO股票行情,WUXI BIO股价,WUXI BIO股市,WUXI BIO股票价格,WUXI BIO股票交易,WUXI BIO股票购买,WUXI BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"WUXI BIO(02269),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest WUXI BIO(02269) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}